Dr. Jose Montoya at Stanford University had a successful outcome
for his first research trial using
Valcyte. I believe the results of his second study are still pending.
Lastly, two-thirds of CFIDS patients have bacterial infections. Another thing to think about is if you are one of these people who have L-form bacteria, then it probably wouldn't be a good idea to take antivirals. Testing for this sub species (and others) mycoplasma is not easy and insurance may not cover the expense.